Loading...

Life Healthcare Group Holdings Limited

LTGHFPNK
Healthcare
Medical - Care Facilities
$0.79
$0.00(0.00%)

Life Healthcare Group Holdings Limited (LTGHF) Financial Performance & Income Statement Overview

View comprehensive annual and quarterly summaries for Life Healthcare Group Holdings Limited (LTGHF), featuring income statements, balance sheets, and cash flow data.

Revenue Growth
12.71%
12.71%
Operating Income Growth
18.86%
18.86%
Net Income Growth
1728.41%
1728.41%
Operating Cash Flow Growth
-20.28%
20.28%
Operating Margin
11.36%
11.36%
Gross Margin
69.78%
69.78%
Net Profit Margin
18.92%
18.92%
ROE
40.28%
40.28%
ROIC
15.20%
15.20%

Life Healthcare Group Holdings Limited (LTGHF) Income Statement & Financial Overview

Access detailed annual and quarterly income data for Life Healthcare Group Holdings Limited LTGHF financial performance.

MetricQ4 2024Q2 2024Q4 2023Q2 2023
Revenue$13.93B$5.93B$7.35B$15.29B
Cost of Revenue$9.50B$4.27B$6.50B$13.90B
Gross Profit$4.43B$1.66B$849.00M$1.39B
Gross Profit Ratio$0.32$0.28$0.12$0.09
R&D Expenses$0.00$0.00$0.00$0.00
SG&A Expenses$1.51B$1.10B$0.00$492.00M
Operating Expenses$2.62B$1.11B$0.00$1.02B
Total Costs & Expenses$12.12B$5.38B$6.50B$13.90B
Interest Income$0.00$158.00M$99.00M$60.00M
Interest Expense$0.00$220.00M$161.00M$417.00M
Depreciation & Amortization$367.00M$612.00M$43812.00$1.20B
EBITDA$2.26B$1.87B$1.15B$2.54B
EBITDA Ratio$0.16$0.32-$0.03$0.17
Operating Income$1.81B$550.50M$849.00M$1.39B
Operating Income Ratio$0.13$0.09$0.12$0.09
Other Income/Expenses (Net)-$129.00M$491.50M$135.00M-$473.00M
Income Before Tax$1.68B$1.04B$984.00M$918.00M
Income Before Tax Ratio$0.12$0.18$0.13$0.06
Income Tax Expense$227.00M$311.00M$178.00M$305.00M
Net Income$1.33B$3.50B-$283.00M$547.00M
Net Income Ratio$0.10$0.59-$0.04$0.04
EPS$0.89$2.43-$0.20$0.38
Diluted EPS$0.90$2.41-$0.20$0.38
Weighted Avg Shares Outstanding$1.47B$1.44B$1.44B$1.44B
Weighted Avg Shares Outstanding (Diluted)$1.46B$1.45B$1.44B$1.45B

Over the past four quarters, Life Healthcare Group Holdings Limited demonstrated steady revenue growth, increasing from $15.29B in Q2 2023 to $13.93B in Q4 2024. Operating income reached $1.81B in Q4 2024, maintaining a consistent 13% margin over recent quarters. Despite fluctuations in R&D and SG&A expenses, EBITDA remained robust at $2.26B, reflecting operational efficiency. Net income dropped to $1.33B, with EPS at $0.89. Disciplined expense management helped sustain profitability, highlighting solid overall financial performance.

Unlock 25+ Years of Financial Data

Get access to extended historical data, advanced metrics, and more with our premium plan

Frequently Asked Questions

;